Table 4 Assessment of complications post UAE in patients with large fibroids compared with a control group (Parthipun et al., 2010; Katsumori et al., 2003; Prollius et al., 2004; Firouznia et al., 2008; Choi et al., 2013; Bérczi et al., 2015; Mollier et al., 2020)
From: Uterine artery embolisation: fertility, adenomyosis and size – what is the evidence?
Study, year | Study design | Period | Cohort size (n) | Giant fibroids / large volume uterus (n) | Non giant fibroids (n) | Giant Fibroid size | Uterine volume | Follow up (months) | Increased risk of major complications in giant fibroid group | Increased risk of major complications in large volume uterus group |
|---|---|---|---|---|---|---|---|---|---|---|
Katsumori et al., 2003 | Retrospective cohort | NR | 152 | 47 | 105 | > 10 cm | NR | 17.5 | No | No |
Prollius et al., 2004 | Prospective cohort | NR | 64 | 12 (18.8%) | 52 | NR | >780cm3 | 12 | No | No |
Firouznia et al., 2008 | Retrospective cohort | 2001–2006 | 101 | NR | NR | NR | NR | 12 | No | No |
Parthipun et al., 2010 | Prospective cohort | 2004–2008 | 121 | 30 | 91 | > 10 cm | >750cm3 | 12 | No | No |
Choi et al., 2013 | Retrospective cohort | 2005–2011 | 323 | 63 | 260 | > 10 cm | >700cm3 | 12–84 | No | No |
Berczi et al., 2015 | Retrospective cohort | 2008–2012 | 303 | 41 | 262 | > 10 cm | NR | 8 | No | No |
Mollier et al., 2020 | Retrospective cohort | 2013–2018 | 333 | NR | NR | > 10 cm | > 1000 cm3 | NR | No | Yes |